Therefore, it is suggested that 6-gingerol reduces the extent of lipogenesis by downregulating lipogenic transcription factors, such as SREBP-1, PPARγ, and C/EBPα, leading to a reduced expression of FAS, which, in turn, attenuates hyperlipidemia associated with adiposity. The gene discussed is SREBF1; the disease is hyperlipidemia.